XPO, Inc. Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net
XPO, Inc. (XPO) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of -$14.20 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2017-11-06
- XPO, Inc. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-09-30 was -$14.20M.
- XPO, Inc. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-06-30 was -$28.30M, a 605.36% decline year-over-year.
- XPO, Inc. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-03-31 was -$10.20M.
- XPO, Inc. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2016-12-31 was $41.00M.
- XPO, Inc. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2016 was $44.20M.
- XPO, Inc. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2015 was -$10.70M.
- XPO, Inc. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2014 was $0.00.
- XPO, Inc. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2013 was $0.00.
| Period end | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$14.20M 10-Q · filed 2017-11-06 | -$42.50M derived: sum of 2 quarters · filed 2017-11-06 | -$52.70M 10-Q · filed 2017-11-06 | -$11.70M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | -$28.30M 10-Q · filed 2017-08-04 | -$38.50M 10-Q · filed 2017-08-04 | $2.50M derived: sum of 3 quarters · filed 2017-08-04 | $2.30M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | -$10.20M 10-Q · filed 2017-05-09 | $30.80M derived: sum of 2 quarters · filed 2017-05-09 | $30.60M derived: sum of 3 quarters · filed 2017-11-06 | $36.20M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | $41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $40.80M derived: sum of 2 quarters · filed 2017-11-06 | $46.40M derived: sum of 3 quarters · filed 2017-11-06 | $44.20M 10-K · filed 2017-02-28 |
| 2016-09-30 | -$200.00K 10-Q · filed 2017-11-06 | $5.40M derived: sum of 2 quarters · filed 2017-11-06 | $3.20M 10-Q · filed 2017-11-06 | -$7.50M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | $5.60M 10-Q · filed 2017-08-04 | $3.40M 10-Q · filed 2017-08-04 | -$7.30M derived: sum of 3 quarters · filed 2017-08-04 | -$7.30M derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | -$2.20M 10-Q · filed 2017-05-09 | -$12.90M derived: sum of 2 quarters · filed 2017-05-09 | -$12.90M derived: sum of 3 quarters · filed 2017-05-09 | -$12.90M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | -$10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$10.70M derived: sum of 2 quarters · filed 2017-02-28 | -$10.70M derived: sum of 3 quarters · filed 2017-02-28 | -$10.70M 10-K · filed 2017-02-28 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GATX CORP (GATX) | United States | $6.476B | 17.01 |
| GXO Logistics, Inc. (GXO) | United States | $5.065B | 44.43 |
| Global Business Travel Group, Inc. (GBTG) | United States | $4.949B | 53.22 |
| RXO, Inc. (RXO) | United States | $3.287B | -43.33 |
| LINDBLAD EXPEDITIONS HOLDINGS, INC. (LIND) | United States | $1.810B | |
| VERRA MOBILITY Corp (VRRM) | United States | $0.492B | 14.56 |
| Virgin Galactic Holdings, Inc (SPCE) | United States | $0.486B | -1.64 |
| Proficient Auto Logistics, Inc (PAL) | United States | $0.106B | -4.59 |
| NextTrip, Inc. (NTRP) | United States | $0.028B | |
| Booking Holdings Inc. (BKNG) | United States | $118.267B | 1.00 |